TARIFF RATE ON ALL DUTIABLE GOODS IMPORTED FOR PERSONAL USE TO BE REDUCED FROM 20% TO 10%

1. At a Glance

• Customs duty proposal in Union Budget 2026-27: tariff rate on all dutiable goods imported for personal use slashed from 20% to 10% [S1][S2].
• Part of a broader push to simplify the tariff structure, support domestic manufacturing, promote export competitiveness, and correct duty inversions [S1][S3].
• Bundled with BCD exemption on 17 drugs/medicines (cancer focus), addition of 7 rare diseases to the exemption list, and trade-facilitation measures for AEOs and exporters [S1].
• UPSC relevance: GS-III (Indian Economy — fiscal policy, taxation, trade), GS-II (Health — drug affordability), Prelims (Budget current affairs).

2. Why in the News

• Announced by Union Finance Minister Smt. Nirmala Sitharaman on 1 February 2026 while presenting the Union Budget 2026-27 [S1].
• Forms part of the Customs and Central Excise proposals in the Finance Bill 2026 [S1][S3].

3. Background & Evolution

• Tariff on personal-use dutiable imports (broadly governed under Heading 9804 of the Customs Tariff) has historically been a flat consolidated rate, last pegged at 20%.
• Continues the tariff rationalisation drive begun in Budget 2025-26, which had already removed seven customs tariff rates for industrial goods, leaving a leaner rate structure [S4].
• The 2026-27 cut deepens the simplification agenda by aligning personal-use rates with the lower industrial rate slabs.

4. Core Static Facts

• Implementing Ministry: Ministry of Finance, Department of Revenue; administered by CBIC (Central Board of Indirect Taxes and Customs) [S1].
• Enabling instrument: Finance Bill 2026 (amendments to the Customs Tariff Act, 1975) [S1][S3].
• Old rate: 20% on dutiable goods imported for personal use [S1].
• New rate: 10% [S1].
• Allied measures announced same day [S1]:
• BCD exemption on 17 drugs/medicines — particularly for cancer patients.
• 7 more rare diseases added to the list for duty-free personal import of drugs and Food for Special Medical Purposes (FSMP).
• AEO Tier-2 & Tier-3 duty-deferral period enhanced from 15 to 30 days.
• Export cargo with electronic sealing to be cleared from factory premises directly to ship.
• Constitutional anchor: Customs duties levied under Entry 83, Union List, Seventh Schedule; Budget tabled under Article 112 (Annual Financial Statement).

5. Multi-Dimensional Analysis

Economic - Reduces effective cost of personal imports (gifts, courier parcels, baggage above free allowance) — boosts consumer welfare but may marginally dent customs revenue [S1][S2]. - Signals tariff moderation; aligns India with WTO-promoted simpler tariff regimes. - AEO deferral extension (15→30 days) eases working-capital pressure for compliant importers [S1].

Social / Health - BCD exemption on 17 cancer-related drugs and 7 added rare diseases under FSMP regime makes life-saving imports cheaper for patients [S1]. - Personal-use tariff cut benefits diaspora remitters and small parcel recipients.

Administrative / Trade Facilitation - Electronic sealing for factory-to-ship export clearance reduces dwell time and aligns with Turant Customs / Faceless Assessment reforms [S1]. - Extending AEO Tier-2/3 benefits deepens India's Authorised Economic Operator programme (a WCO SAFE Framework concept).

Legal / Constitutional - Customs tariff changes require parliamentary assent via the Finance Bill; immediate effect under the Provisional Collection of Taxes Act, 2023.

6. Recent Developments (last 12-18 months)

• 1 Feb 2026 — Tariff cut from 20%→10% announced in Union Budget 2026-27 [S1].
• Feb 2026 — Budget speech and Summary released by PIB (PRID 2221455, 2221458) [S2].
• Budget 2025-26 — Earlier round: 7 customs tariff rates removed for industrial goods [S4].
• 2026 — CBIC notified Conditional Concessional Customs Duty for SEZ-to-DTA sales as a one-time relief, following Budget 2026-27 announcement [S5].

7. Prelims Hooks

• Tariff on dutiable goods imported for personal use reduced from 20% to 10% in Budget 2026-27 [S1].
• Announced by Nirmala Sitharaman on 1 February 2026 [S1].
• 17 drugs/medicines exempted from Basic Customs Duty, focus on cancer patients [S1].
• 7 additional rare diseases added to duty-exempt personal import list [S1].
• FSMP = Food for Special Medical Purposes — covered under rare disease exemption [S1].
• AEO Tier-2 and Tier-3 duty deferral extended from 15 days to 30 days [S1].
• Export cargo with electronic sealing to get clearance from factory to ship [S1].
• Personal-use imports broadly fall under Heading 9804 of the Customs Tariff.
• Implementing body: CBIC, under Department of Revenue, Ministry of Finance [S1].
• Customs is Entry 83 of Union List, Seventh Schedule.
• Budget 2025-26 had removed 7 customs tariff rates for industrial goods [S4].
• AEO programme derives from WCO SAFE Framework of Standards.

8. Mains Relevance

• GS-III: Indian Economy — Government Budgeting; Effects of liberalization on the economy; Indirect taxation.
• GS-II: Government policies/interventions in health (rare diseases, cancer drugs affordability).
• Possible question stems: 1. "Tariff rationalisation in recent Union Budgets reflects a shift from protectionism to facilitation." Examine with reference to Budget 2026-27 customs proposals. 2. Discuss how customs duty exemptions on drugs for rare diseases and cancer balance fiscal cost against public health goals. 3. Evaluate the role of the Authorised Economic Operator (AEO) programme in India's trade facilitation architecture.

9. Related Topics to Study Next

• Authorised Economic Operator (AEO) Programme — directly impacted by 15→30 day deferral.
• National Policy for Rare Diseases, 2021 — context for the 7-disease addition.
• Customs Tariff Act, 1975 & Finance Bill 2026 — enabling statute.
• Faceless Assessment / Turant Customs — sibling trade facilitation reform.
• WTO Trade Facilitation Agreement (2017) — multilateral backdrop.
• Production Linked Incentive (PLI) schemes — complementary "support domestic manufacturing" lever.
• Inverted Duty Structure — the "correction" the Budget cites.
• Provisional Collection of Taxes Act, 2023 — enables immediate effect of customs changes.

10. Common Errors / Trap Areas

• Wrong scope: The cut applies to personal-use dutiable goods, NOT to all customs imports or all baggage (which has separate duty-free allowance rules).
• Confusing ministries: Customs is under Ministry of Finance / CBIC, not Ministry of Commerce.
• Drug count: 17 drugs newly BCD-exempt; 7 rare diseases added — aspirants often swap these numbers.
• AEO tiers: Deferral extension applies to Tier-2 & Tier-3 only (not Tier-1).
• Year confusion: Removal of 7 tariff rates was Budget 2025-26; the 20→10% cut is Budget 2026-27.
• Heading 9804 is for personal-use imports — not to be confused with general baggage rules under the Baggage Rules, 2016.

11. Sources

• [S1] Tariff Rate on All Dutiable Goods Imported for Personal Use to Be Reduced from 20% to 10% — https://www.pib.gov.in/PressReleasePage.aspx?PRID=2221439 — (tier 1)
• [S2] Summary of Union Budget 2026-27 (PIB) — https://www.pib.gov.in/PressReleasePage.aspx?PRID=2221458 — (tier 1)
• [S3] Budget Proposals for Customs and Central Excise Aim to Further Simplify Tariff Structure — https://www.pib.gov.in/PressReleasePage.aspx?PRID=2221446 — (tier 1)
• [S4] Union Budget 2025-26 Proposes to Remove Seven Customs Tariff Rates for Industrial Goods — https://www.pib.gov.in/PressReleasePage.aspx?PRID=2098364 — (tier 1)
• [S5] CBIC Conditional Concessional Customs Duty for SEZ to DTA Sales — https://www.pib.gov.in/PressReleasePage.aspx?PRID=2247993 — (tier 1)